A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01849874

Recruitment Status : Active, not recruiting

First Posted : May 9, 2013

Last Update Posted : February 8, 2021

Sponsor:

Information provided by (Responsible Party):

Pfizer

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	December 1, 2015
Estimated Study Completion Date :	June 30, 2021
Certification/Extension First Submitted :	April 3, 2017

To Top